Beat BioTherapeutics completes venture financing

Beat BioTherapeutics Corp., Seattle, Wash. Business: Cardiovascular Date completed: 4/16/13 Type: Venture financing Raised: $2.5 million Investors: CET Capital Partners; W Fund Note: The financing was...